SEC Form 4 · accession 0000059478-18-000159
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Christi Shaw
Officer — SVP and Pres., Lilly Bio-Meds
Period of report
May 29, 2018
Accepted (ET)
May 31, 2018 · 1:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 29, 2018 | S | 8,426 | $82.10 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.